Bio/Pharma News

FDA Approves Dalizumab

June 02, 2016

FDA approved dalizumab a monoclonal antibody for the treatment of multiple sclerosis.

Jazz Pharmaceuticals Acquires Celator

May 31, 2016

Jazz will acquire Celator for approximately $1.5 billion.

Xellia Builds Testing Services Lab at Budapest Manufacturing Site

May 27, 2016

Xellia, a generic anti-infective drug manufacturing company, is constructing a laboratory services building at its manufacturing site in Budapest, Hungary.

FDA Accepts Samsung Bioepis' BLA for Remicade Biosimilar

May 24, 2016

FDA accepted for review Samsung Bioepis’ BLA for SB2, a biosimilar to Remicade (infliximab).

Sanofi Makes Changes to Executive Committee

May 23, 2016

Sanofi announced that it is making several changes to its executive committee, effective June 1, 2016.

FDA Approves Atezolizumab

May 19, 2016

Genentech received accelerated approval for its immunotherapy atezolizumab for the treatment of bladder cancer.

Celgene and Agios Collaborate on Metabolic Immuno-Oncology

May 19, 2016

Celgene will pay Agios $200 million to lead exploratory, research, drug discovery, and early development work for metabolic immuno-oncology.

Pfizer to Acquire Anacor

May 16, 2016

Pfizer will acquire Anacor for $5.2 billion and expects the transaction to complete in the third-quarter of 2016.

Caribou Biosciences Completes Series B Financing Round

May 16, 2016

Caribou announced the completion of a $30-million Series B financing round, which included the participation of new and current investors.

AXIM Begins Clinical Trials with CBG Ointment

May 16, 2016

The Phase I trials will examine AX-1602’s clinical efficacy for the treatment of psoriasis and eczema.